| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | CA2418104A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | CA2416748A1 Improved specificity in treatment of diseases |
| 02/28/2002 | CA2415846A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181382A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181366A1 Mammalian receptor proteins; related reagents and methods |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181284A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 02/27/2002 | EP1181276A1 Morpholino-n-ethyl ester derivative of an indole spla-2 inhibitor |
| 02/27/2002 | EP1181275A1 Thio-oxindole derivatives |
| 02/27/2002 | EP1181270A2 Inhibitors of factor xa |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | EP1181052A1 Protein a based binding domains with desirable activities |
| 02/27/2002 | EP1181048A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| 02/27/2002 | EP1181036A1 Pharmaceutical compositions of erythropoietin |
| 02/27/2002 | EP1181030A2 Tanacetum parthenium extract |
| 02/27/2002 | EP1181021A1 Novel, specific inhibitors of acute and chronic inflammation |
| 02/27/2002 | EP1181017A1 Metalloprotease inhibitors |
| 02/27/2002 | EP0859634B1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 02/27/2002 | EP0831887B1 Therapy using lymphotoxin and thrombopoietin |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | CN1337963A Pirazino (aza) indole derivatives |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337246A Chinese medicine for treating cerebral thrombus sequelae |
| 02/27/2002 | CN1337234A Compound alum powder and its prepn |
| 02/27/2002 | CN1079796C Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use |
| 02/26/2002 | US6350774 Antithrombotic agents |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350761 Benzenamine derivatives as anti-coagulants |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350746 Benzamidine derivatives and their use as anti-coagulants |
| 02/26/2002 | US6350745 Thrombin inhibitors |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2078875C High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/26/2002 | CA2038030C Synthetic peptides which contain sequences from factor viia, and the use thereof |
| 02/21/2002 | WO2002014488A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014353A1 Anti-heparin peptides |
| 02/21/2002 | WO2002014349A2 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014308A1 Antithrombotic agents |
| 02/21/2002 | WO2002014307A1 Factor viia inhibitors |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014283A1 Processes for preparing cilostazol |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors |
| 02/21/2002 | WO2002013882A1 Implants with a phosphazene-containing coating |
| 02/21/2002 | WO2002013872A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/21/2002 | WO2002013823A1 Micronized torsemide |
| 02/21/2002 | WO2002013798A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | WO2002013758A2 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | WO2001090063A3 Prodrug of an ice inhibitor |
| 02/21/2002 | WO2001085256A3 Critical illness neuropathy |
| 02/21/2002 | WO2001082943A3 Subcutaneous administration of coagulation factor vii |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001062901A3 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 02/21/2002 | WO2001055175A3 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/21/2002 | WO2001032871A3 Follistatin-related protein zfsta4 |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001030300A3 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | US20020022816 Device |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022648 Novel 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| 02/21/2002 | US20020022645 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | US20020022617 Methods for increasing nitric oxide synthase activity |
| 02/21/2002 | US20020022615 Cyclic oxyguanidine protease inhibitors |
| 02/21/2002 | US20020022612 Nitrogen containing heterocyclic compounds useful as anticoagulants |
| 02/21/2002 | US20020022610 Compositions and methods for treating bacterial infections |
| 02/21/2002 | US20020022604 4-oxo-4h-pyran derviatives; use as inhibitors of serine proteases; anticoagulants; treating thrombotic conditions including coronary artery and cerebrovascular diseases |
| 02/21/2002 | US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
| 02/21/2002 | US20020022236 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 02/21/2002 | US20020022061 Anticoagulant mixture |
| 02/21/2002 | US20020022060 Combined plant coagulate composition, process for the manufacture thereof and uses thereof |
| 02/21/2002 | US20020022025 Anticoagulants |
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419181A1 Processes for preparing cilostazol |
| 02/21/2002 | CA2419081A1 Micronized torsemide |
| 02/21/2002 | CA2419033A1 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |